Medical BD Manager
Medical BD Manager
WHO WE ARE
We are EssilorLuxottica, a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. The Company brings together the complementary expertise of two industry pioneers, one in advanced lens technologies and the other in the craftsmanship of iconic eyewear, to create a vertically integrated business that is uniquely positioned to address the world’s evolving vision needs and the global demand of a growing eyewear industry.
With over 180,000 dedicated employees in 150 countries driving our iconic brands, our people are creative, entrepreneurial and celebrated for their unique perspectives and individuality. Committed to vision, we enable people to “see more and be more” thanks to our innovative designs and lens technologies, exceptional quality and cutting-edge processing methods. Every day we impact the lives of millions by changing the way people see the world
Your role
BD Manager will be responsible for identifying and developing new business opportunities within the medical channel, with a focus on hospitals, eye-care institutions, clinic groups and other strategic medical partners.
This role will lead the development of new partnership models, strategic projects and professional solutions that support sustainable business growth. The successful candidate will work closely with sales, marketing, professional sales, channel management and other cross-functional teams to translate market opportunities into scalable and commercially viable initiatives.
Main responsibilities:
• Identify and evaluate new business opportunities across hospitals, eye-care institutions, clinic groups and other medical partners.
• Design innovative cooperation models and professional solutions based on customer needs, market trends and business priorities.
• Lead business discussions, proposal development, commercial negotiations and partnership agreements.
• Build and maintain strong relationships with key decision-makers and stakeholders within the medical channel.
• Lead strategic business development projects from opportunity assessment and business-case development through pilot implementation and scale-up.
• Develop clear project plans, milestones, resource requirements and success measures.
• Coordinate cross-functional teams to ensure effective execution and timely delivery.
• Track project performance, identify potential risks and recommend corrective actions.
• Capture pilot learnings and translate successful initiatives into replicable business models
• Act as the primary contact window between our organization and key customers, ensuring seamless communication and alignment on joint business objectives.
• Work closely with cross-functional teams to ensure BD initiatives are operationally feasible.
• Coordinate with regional sales teams to ensure local execution aligns with business strategies and partner commitments.
Main requirements:
• Bachelor’s degree or above in Medicine, Pharmacy, Medical Devices, Life Sciences, Biomedical Engineering, or a related discipline.
• Minimum of 5–8 years of experience in business development and commercial strategy within the pharmaceutical, medical device, or vision care industry.
• Proven experience in driving product entry and adoption in hospitals and other clinical settings – familiar with bidding, clinical evaluation processes, and hospital compliance management.
• Strong commercial mindset with expertise in sales strategy, brand management, Strategic thinker with the ability to translate vision into actionable plans.
• Agile and resilient, skilled at navigating diverse stakeholder interests and reaching win-win outcomes.
• Fluent in English and local language (both written and spoken), with strong presentation.
• Proactive and self-driven attitude, thrives for problem-solving actions.
相关新闻
直销渠道与可穿戴设备驱动依视路陆逊梯卡第三季度营收达74.9亿欧元
法意眼镜巨头依视路陆逊梯卡(EssilorLuxottica)宣布,2026年第三季度合并营收达74.9亿欧元(约合84亿美元)。按固定汇率计算,同比增长7.2%;按现行汇率计算,增幅为9%。 今年前九个月,集团合并营收按固定汇率计算增长8.9%,达223亿欧元。零售渠道与各地区的全面扩张,叠加可穿戴设备与近视管理业务的持续增长动能,共同支撑了季度营收的提升。 直销部门引领季度增长 直销(D2C)部门是本季度的核心业绩驱动力,第三季度营收达40.9亿欧元。该部门按固定汇率计算增长10.6%,得益于可比门店销售额的高个位数增长,以及新纳入合并范围的眼科诊所业务贡献。实体光学及太阳镜零售品牌均录得正增长,电商表现略有提升,占公司总营收的7%。 专业解决方案部门营收为33.9亿欧元,按固定汇...
商务会员loading...
EssilorLuxottica 2026年第一季度营收增长10.8%
EssilorLuxottica于周三公布,其2026年第一季度合并营收达到71.27亿欧元,按固定汇率计算,相较于2025年同期的68.48亿欧元,同比增长10.8%。 按当前汇率计算,营收增长了4.1%。 其中,专业解决方案部门营收为33.62亿欧元,较2025年第一季度增长10.8%;直接面向消费者(DTC)部门营收为37.64亿欧元,增长10.7%。 EssilorLuxottica董事长兼首席执行官Francesco Milleri与副首席执行官Paul du Saillant评论道:“凭借连续第三个季度的双位数增长,我们再次证明了公司战略的实力与价值,以及我们卓越的执行能力。在所有地区和业务领域,我们都保持了强劲的发展势头,这得益于我们视力保健和眼镜业务的稳固基础以及持续不...
商务会员loading...